BRTS MEIA ORA OUE 27 1 UY 18 NTew Drugs Antithrombotic treatment

Abstract

Recent advances in the management of thrombotic disease have mainly been in prevention-for instance, prophylaxis of deep venous thrombosis. This article is confined to the use of drugs as possible prophylactic agents-namely, the antiplatelet drugs, low dose heparin, dextran, and ancrod. All of these drugs are still being examined in different clinical settings, and the intention is to discuss the current state of evaluation of their clinical efficacy.

Cite this paper

@inproceedings{BUCKLER2006BRTSMO, title={BRTS MEIA ORA OUE 27 1 UY 18 NTew Drugs Antithrombotic treatment}, author={P BUCKLER and Alexander S. Douglas}, year={2006} }